Ceapro Inc. to Present at the Virtual Investor Roundtable Event
Ceapro Inc. (OTCQX: CRPOF), a biotechnology company, will participate in a Virtual Investor Roundtable Event on November 17, 2021, at 11:00 AM ET. The event will feature a presentation by CEO Gilles Gagnon, followed by a moderated roundtable discussion and a Q&A session. Investors can submit questions live or in advance. A live video webcast will be available on the company's website, with a replay accessible for one year afterward. Ceapro specializes in developing active ingredients for healthcare and cosmetics from oats and other renewable resources.
- None.
- None.
Live moderated video webcast discussion on Wednesday, November 17th at 11:00 AM ET
EDMONTON, Alberta, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, President and Chief Executive Officer of Ceapro will participate in the Virtual Investor Roundtable Event on Wednesday, November 17, 2021 at 11:00 AM ET.
As part of the virtual event, Ceapro Inc. will provide a brief presentation, followed by a moderated roundtable discussion and an interactive Q&A session. In addition to the moderated portion of the event, all investors and interested parties will have the opportunity to submit questions live during the event. Interested parties may also pre-submit questions in advance of the live event, which can be sent via the conference website at virtualinvestorco.com. The Company will answer as many questions as possible during the event.
A live video webcast of the Roundtable Event will be available on the Events page of the Investors section of the Company’s website (ceapro.com). A webcast replay will be available two hours following the live presentation and will be accessible for one year.
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.
For more information contact:
Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
What is the date of Ceapro Inc.'s Virtual Investor Roundtable Event?
Who will represent Ceapro Inc. at the investor event?
How can investors submit questions for Ceapro Inc.'s event?
Where can I watch the Ceapro Inc. investor event live?
What specialty does Ceapro Inc. focus on in biotechnology?
